Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9130270 | 0.82 | USP2 (0.46) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL2057201 | 0.82 | USP2 (0.46) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL1742189 | 0.79 | ALDH1A1 (0.48) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL2103021 | 0.79 | CYP2C19 (0.39) | CYP2C19 | |
| SCHEMBL23674320 | 0.78 | USP2 (0.42) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL21025314 | 0.78 | USP2 (0.42) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL12999204 | 0.78 | USP2 (0.42) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL5717997 | 0.78 | CYP2C19 (0.35) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL15262716 | 0.78 | USP2 (0.42) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL1965705 | 0.78 | USP2 (0.42) | USP2TSHRKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279160-A1 | METHOD FOR SYNTHESIZING 9-AMINOMETHYL TETRACYCLINE COMPOUNDS | HOVIONE SCIENTIA LIMITED (IE) | 2024-08-22 | — | — | US | disclosed |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. | 2024-02-29 | — | — | US | disclosed |
| EP-3953360-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) | HOFFMANN LA ROCHE (CH) | 2024-02-28 | — | — | EP | disclosed |
| CN-117616008-A | Synthesis method of 9-aminomethyl tetracycline compound | 好利安科技有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117279895-A | (hetero) arylamide compound and pest control agent | 日本曹达株式会社 | 2023-12-22 | — | — | CN | disclosed |
| US-20230277570-A1 | ENPP1 Inhibitors and Their Use for the Treatment of Cancer | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2023-09-07 | — | — | US | disclosed |
| CN-113453554-B | herbicidal composition | 先正达农作物保护股份公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-111032640-B | Herbicidal compounds | 先正达参股股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-3923724-B1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-07-26 | — | — | EP | disclosed |
| US-11618743-B2 | Herbicidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2023-04-04 | — | — | US | disclosed |
| US-7365091-B2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX | ENOBIA PHARMA (CA) | 2008-04-29 | — | — | US | disclosed |
| US-20080064718-A1 | INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY | METHYLGENE INC. (CA) | 2008-03-13 | — | — | US | disclosed |
| US-20070293530-A1 | SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS | METHYLGENE INC. (CA) | 2007-12-20 | — | — | US | disclosed |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-10-25 | — | — | US | disclosed |
| US-7271188-B2 | Imidazolidine derivatives | CHUGAI SEIKAYU KABUSHIKI KAISHA (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7271188-B2 | Imidazolidine derivatives | CHUGAI SEIKAYU KABUSHIKI KAISHA (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20070015026-A1 | Membrane-electrode assembly for solid polymer electrolyte fuel cell | HONDA MOTOR CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070015026-A1 | Membrane-electrode assembly for solid polymer electrolyte fuel cell | HONDA MOTOR CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-6204386-B1 | PYRIDINIUM COMPOUND | ARTEVA NORTH AMERICA S.A.R.L. (CH) | 2001-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11618743-B2 | Herbicidal compounds | DDT, ACHE, GSTO1 | USP2 2000/4885TSHR 1475/4885KDM4E 1194/4885 |
| US-20080064718-A1 | INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY | HGF, ERBB2, MET | USP2 2806/4885TSHR 1253/4885KDM4E 2282/4885 |
| US-20240279160-A1 | METHOD FOR SYNTHESIZING 9-AMINOMETHYL TETRACYCLINE COMPOUNDS | TET1, TET3, TET2 | USP2 1854/4885TSHR 1415/4885KDM4E 299/4885 |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | TPX2, H1-4, MAPT | USP2 3595/4885TSHR 1144/4885KDM4E 743/4885 |
| US-20070293530-A1 | SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC11, HAT1 | USP2 1411/4885TSHR 1262/4885KDM4E 215/4885 |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CYP3A4, CYP4B1, OPRD1 | USP2 3695/4885TSHR 1646/4885KDM4E 1337/4885 |
| US-20230277570-A1 | ENPP1 Inhibitors and Their Use for the Treatment of Cancer | ENPP1, ENPP3, ENTPD1 | USP2 855/4885TSHR 3941/4885KDM4E 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.